Recent genetic studies in Drosophila and mouse have uncovered a new aspect of the Wnt signal transduction machinery. Mutations disrupting LDL-receptor related proteins produce loss-of-function Wnt phenotypes, suggesting that these cell surface molecules may represent essential co-receptors for Wnt ligands.
New evidence from flies, frogs and mice indicates that the Wnt receptor complex may be more complicated still. Three recent papers [7] [8] [9] report the potential role of low density lipoprotein (LDL) receptor-related proteins (LRPs) in Wnt pathway activity. Mutations in the fly gene arrow, which encodes an LRP homolog, were originally identified in the embryonic patterning defect screens of Wieschaus and Nüsslein-Volhard [10] . The segment polarity phenotype of homozygous arrow mutants shows subtle alterations to the epidermal pattern. The DiNardo group [7, 11] recognized that this pattern is reminiscent of a late loss of Wg activity, inspiring them to determine whether the maternal contribution of arrow masked a more dramatic effect on embryogenesis. Removal of both maternal and zygotic arrow gene product was found to result in severe pattern disruptions, phenocopying exactly the effects of complete loss of Wg activity in embryos. Both wg null mutants and embryos derived from arrow germ-line clones show a profound reduction in cell-fate diversity, reflected in the cuticular elements secreted by the epidermal cells, as well as a loss of Wg target gene expression. The gene responsible for the arrow mutant phenotype was cloned and found to be homologous to two vertebrate genes, LRP5 and LRP6, the products of which define a subclass of LDL-receptor related proteins [12] .
In parallel work, the mouse LRP6 was mutated in a genetrap screen designed to recover recessive lethal phenotypes resulting from disruption of cell surface proteins [9] . The embryonic phenotype resulting from this insertional mutation is pleiotropic, resembling a composite of the phenotypes produced by loss-of-function mutations in a subset of the mouse Wnt genes. For example, the lrp6 homozygotes show defects in midbrain/hindbrain morphogenesis similar to those of Wnt-1 mutant mice, axis truncation similar to that of Wnt-3a mutant mice, and limb patterning defects reminiscent of Wnt-7a mutant mice. In all cases, the severity is greater in the Wnt mutant, suggesting that loss of LRP6 function does not completely abrogate Wnt function, as loss of arrow function does in the fly. This may reflect overlapping activity with the other mouse Arrow homolog, LRP5. Despite this possible redundancy, the lrp6 mutant phenotype is robust enough to show a dose-dependent interaction with the hypomorphic Wnt-3a mutation, vestigial tail (vt): mice that are both homozygous for the vt allele and heterozygous for the lrp6 mutation have tails significantly shorter than those of vt homozygotes. Subsequent work with the frog Xenopus [8] demonstrated that blastomere injection of LRP6 RNA at a high dosage produces axis duplications, similar to those observed with high-dose injections of Wnt RNA. Moreover, the coinjection of LRP6 and Wnt RNA at low doses, which individually do not produce axis duplication, was found to have a synergistic axis-duplicating effect. LRP5 RNA injection also produced axis duplication and synergy with Wnt RNA, though only at higher doses than those required with LRP6 RNA. This supports the idea that there may be some functional redundancy between LRP5 and LRP6.
The Arrow, LRP5 and LRP6 proteins show significant sequence homology and are somewhat diverged from other LDL-receptor related proteins [7] . The LDL receptor and all of the LDL-receptor related proteins have multiple copies of both the EGF repeat and the so-called LDL receptor repeat, both of which are thought to mediate interactions with specific ligands [12] . In the LDL receptor family, these repeats generally are arranged so that the LDL receptor repeats are amino-terminal to the EGF repeats, but this order is reversed in the Arrow/LRP5/LRP6 subgroup ( Figure 1 ). These molecules have three widely spaced EGF repeats, followed by three tightly grouped LDL receptor repeats positioned just amino-terminal to the transmembrane domain. All three proteins show regions of significant homology outside of these repeats, including sequences within the cytosolic domain. This domain, which in all three proteins is just over 200 amino acids long, is rich in prolines and serines, does not bear any resemblance to any other known protein and has no obvious catalytic motifs. The behaviors of Arrow and LRP6 in vivo are consistent with a function in Wnt reception, rather than ligand production or presentation. Mutant arrow embryos initially show a normal expression and distribution of Wg protein, indicating that loss of arrow function does not perturb Wg export and transcytosis. In somatic arrow mutant clones, Wg target-gene expression is lost in a cellautonomous fashion, suggesting that Arrow acts in the responding cell (Figure 2a,b) . The embryonic arrow mutant phenotype is rescued by overproduction of Dsh, but not by overproduction of the Wg ligand. These data position Arrow function between the signal and the most upstream intracellular Wg effector.
In frogs, the synergistic effect between co-injected LRP6 and Wnt-5a RNAs is observed even when each is injected individually into adjacent blastomeres (Figure 2c,d These results imply that LDL-receptor-related proteins act at the cell surface, perhaps as part of the Wnt receptor complex. Indeed, the extracellular portion of LRP6 interacts with the extracellular portion of a mouse Frizzled protein, and does so only when Wnt-1 is present in the medium [8] . Thus, either the Wnt ligand forms a bridge between the two receptors, or it changes the conformation of one receptor to allow interaction with the other. In any case, the mutational analysis in flies clearly demonstrates that Arrow is an essential component of Wg signaling and that the Fz receptors cannot activate the Wg intracellular cascade in its absence. This differs from the influence of proteoglycans on Wg signal transduction. Disruptions caused by mutations in sugar modification enzymes, or in the proteoglycan core protein Dally itself, can be reversed by overproducing Wg [13] . Proteoglycans thus appear to facilitate Wg signaling by concentrating the ligand and/or presenting it efficiently to the receptors; overproduction of the ligand renders this function unnecessary. In contrast, overproducing Wg in arrow mutant embryos does not rescue the phenotype at all [7] , indicating that Arrow function is absolutely required for transduction of the signal. 
